Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The purpose of “TOPGUN: Phaco Mavericks,” said David Chang, MD, is to have the world’s top phaco instructors provide their best pearls in cataract surgery. The symposium, which took place at the 2023 ASCRS Annual Meeting, included two teams—ASCRS members and an international team with members from ESCRS, APACRS, and LASCRS.
➤ Topline data from Phase 3 presbyopia drop trial ➤ Femtosecond laser for LASIK receives FDA clearance ➤ Enrollment complete for hydrophobic trifocal IOL trial ➤ Early results from clinical trial for dry eye therapy ➤ FDA clears IND application for clinical trial of therapy for X-linked retinoschisis ➤ Innovations in capsulotomy creation device ➤ Company acquisition news ➤ ASCRS news and events
➤ FDA approves new monofocal IOL ➤ Topline Phase 3 results for fixed-dose combination presbyopia drop ➤ Gene therapy trial produces positive Phase 1/2 data for Leber congenital amaurosis ➤ New data shows investigational compound protects endothelium for cataract patients undergoing Fuchs treatment ➤ ASCRS news and events
The options and strategies for mixing and matching IOLs have evolved over time. Two surgeons discussed their approaches for using different lenses to help give patients the best outcomes.
Patients with glaucoma who need cataract surgery have many lens options available, and it’s important for physicians to present the potential benefits and risks so patients can make the best decision. Two experienced ophthalmologists discussed different lens options for glaucoma patients and important factors to consider.
➤ Fast-Track Designation granted for persistent epithelial defect treatment ➤ Study: automated capsulotomy device and white cataracts ➤ Dose escalation complete for Phase 1/2 study evaluating an RP treatment ➤ Companies enter agreement for sustained-release glaucoma treatment ➤ ASCRS news and events
As advanced-technology IOLs have become more mainstream and more enter the market, surgeons have refined their understanding and use of these. The EyeWorld
➤ FDA approves twice-daily use of presbyopia drop ➤ Study: drug approved for high blood pressure shows promise for blinding childhood disease ➤ Breakthrough device designation granted to investigational dry AMD therapy ➤ Positive topline results for Phase 2 study of retinitis pigmentosa treatment ➤ FDA approves pediatric enrollment in trial for retinitis pigmentosa and Leber congenital amaurosis ➤ ASCRS news and events
Even with a successful cataract surgery, there are a variety of issues that can pop up postoperatively that can be problematic for patients, warranting further follow-up from the physician. Two physicians discussed some of the most common issues that they see following cataract surgery and how to address them.
Cataract Editor Mitchell Weikert, MD, offers a glimpse into what readers will find in both the ASCRS Annual Meeting Preview section and the Cataract section of the issue.